Linked Life Data

8730501

Source:http://linkedlifedata.com/resource/pubmed/id/8730501

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1996-10-2
pubmed:abstractText
Alpha interferon (alpha IFN) treatment normalizes serum ALT levels in at least half of all patients affected by chronic hepatitis C, but a reactivation of the disease is frequently observed after the end of therapy. Different regimens of alpha IFN therapy have been proposed but the optimal schedule is still controversial. Recently at least 6 different types of HCV have been identified and the HCV genotype has been proposed as an important factor influencing the response to alpha IFN therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed:issnType
Print
pubmed:volume
13 Suppl 13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S167-73
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed:articleTitle
Alpha interferon treatment in chronic hepatitis C.
pubmed:affiliation
Center for Liver Diseases Crespi, Niguarda Hospital, Milan, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial